Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the commercial launch of Zenith genomics, its next-generation whole genome sequencing assay ...
New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...
PhD, FACMG has been elected President of the ACMG Foundation for Genetic and Genomic Medicine. The ACMG Foundation works to advance American College of Medical Genetics and Genomics (ACMG) educational ...
Genomic medicine has the potential to impact all areas of medicine and change clinical practice. In contrast to the trial-and-error of today’s practice, genomic ...
Building on that foundation, the GO Genomic Report generated through this workflow will now include a direct link to the WeTrials platform. With a single click, clinicians can move from a patient's ...
Industry-leading research powered by GeneDx Infinity™ accelerates the transition of genomics from discovery to the standard of clinical care, driving better outcomes for patients across healthcare ...
Findings from the pilot phase of an ONC research program informed an independent set of interoperability standards for genomic data sharing, three ONC officials wrote in a Nov. 28 agency blog post.
The term ‘mainstreaming’ was first used in 2003 by the Secretary of State for Health in the context of the genetics white paper Our Inheritance, Our Future when he argued that genomics must move from ...
This article is authored by Dr Kirti Chadha, chief scientific and innovation officer, Metropolis Healthcare Limited.
Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results